Sibannac Inc (SNNC)
0.0084
0.00 (0.00%)
USD |
OTCM |
May 10, 15:50
Sibannac Cash from Investing (TTM): 0.0401M for Aug. 31, 2016
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
February 28, 2017 | 0.0562M |
November 30, 2016 | 0.016M |
August 31, 2016 | 0.00 |
May 31, 2016 | -0.1444M |
February 29, 2016 | -0.1947M |
November 30, 2015 | -0.1545M |
August 31, 2015 | -0.1385M |
May 31, 2015 | -0.0577M |
February 28, 2015 | 0.0023M |
November 30, 2014 | 0.00 |
Date | Value |
---|---|
August 31, 2014 | |
May 31, 2014 | |
February 28, 2014 | |
November 30, 2013 | |
August 31, 2013 | |
May 31, 2013 | -0.0007M |
February 28, 2013 | -0.0007M |
November 30, 2012 | -0.0007M |
August 31, 2012 | -0.0007M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |
Oragenics Inc | -0.9363M |